Trending
- Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment
- Wellbeing survey shows a third want to leave policing within a year
- Pittsburgh-based start-up targets rare diseases with RK Mellon Foundation grant that could hit $25M
- Chrissy Metz’s transformation in photos: from ‘invisible’ schoolgirl to Hollywood star
- Miami’s largest fitness festival announced its full lineup, with Dwyane Wade and celeb instructors
- Cone Health moves forward with plans to build Mebane hospital
- Men’s Eating Habits Affect the Health of Their Future Children, Study Finds
- Lilly Targets Black
Wednesday, August 12
